MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts. We have supplied over 1.3 Million allografts to date for application in multiple sectors of healthcare.
We process human placental tissue utilizing our proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. We dry preserve human amniotic membrane tissue, resulting in minimally manipulated tissue that is the foundation of our AmnioFix® and EpiFix® products.
Copyright Nasdaq. Minimum 15 minutes delayed.
Copyright West LLC. Minimum 15 minutes delayed.